P04772 Glutamine synthetase MolNFT, Molecular NFT on GenesisL1

Glutamine synthetase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeih5hdfwequuegukdkckyvozfevo65o6li7shl4eeq3awlmbs7gvau/metadata.json

IPFS of structure file:

bafybeicngchpbe7gehixryi2cm4gpmghccqawmurdvfho5sidoskrohaz4/AF-P04772-F1-model_v2.pdb

First NFT owner address (eip-55):

0x8EFd901A9417Db3E794c277E751d8219022562Ec

First NFT owner address (bech32):

genesis13m7eqx55zldnu72vyal828vzrypz2chvs33u6e

Current NFT ID #150854 owner (web3):

0x4a9773C41eA9195713EAB3716E91205C515501aD

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
150854
Accession (UniProt):
P04772
Name::
Glutamine synthetase
Experimental Method:
Predicted structure
Sequence source:
BRADYRHIZOBIUM DIAZOEFFICIENS (STRAIN JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P04772 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P04772|GLNA2_BRADU Glutamine synthetase OS=Bradyrhizobium diazoefficiens (strain JCM 10833 / BCRC 13528 / IAM 13628 / NBRC 14792 / USDA 110) OX=224911 GN=glnII PE=1 SV=2 MTKYKLEYIWLDGYTPTPNLRGKTQIKEFASFPTLEQLPLWGFDGSSTQQAEGHSSDCVLKPVAVFPDAARTNGVLVMCEVMMPDGKTPHASNKRATILDDAGAWFGFEQEYFFYKDGRPLGFPTSGYPAPQGPYYTGVGFSNVGDVARKIVEEHLDLCLAAGINHEGINAEVAKGQWEFQIFGKGSKKAADEMWMARYLMLRLTEKYGIDIEFHCKPLGDTDWNGSGMHANFSTEYMRTVGGKEYFEALMAAFDKNLMDHIAVYGPDNDKRLTGKHETAPWNKFSYGVADRGASIRVPHSFVNNGYKGYLEDRRPNSQGDPYQIASQILKTISSVPTEKKAVA

P04772 AF NFT

MOLNFT AF v1

NFT data

MOLNFT P04772 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience